Home Cart Sign in  
Chemical Structure| 872599-83-2 Chemical Structure| 872599-83-2

Structure of Epelsiban
CAS No.: 872599-83-2

Chemical Structure| 872599-83-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GSK 557296 is a potent, selective and orally bioavailable oxytocin receptor antagonist, with a pKi of 9.9 for human oxytocin receptor.

Synonyms: GSK 557296

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Epelsiban

CAS No. :872599-83-2
Formula : C30H38N4O4
M.W : 518.65
SMILES Code : O=C([C@@H](C1CC2=C(C=CC=C2)C1)N3)N([C@H](C4=CC=C(C)N=C4C)C(N5CCOCC5)=O)[C@H]([C@@H](C)CC)C3=O
Synonyms :
GSK 557296
MDL No. :MFCD26961099

Safety of Epelsiban

Related Pathways of Epelsiban

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02794467 Adenomyosis Phase 2 Withdrawn(Study was prematurel... More >>y discontinued due to GSK's change in prioritization for the portfolio and is not due to any safety concerns or regulatory interaction.) Less << October 2016 United States, District of Col... More >>umbia GSK Investigational Site Washington, DC, District of Columbia, United States, 20036 United States, Florida GSK Investigational Site West Palm Beach, Florida, United States, 33409 United States, Illinois GSK Investigational Site Champaign, Illinois, United States, 61820 United States, Louisiana GSK Investigational Site Mandeville, Louisiana, United States, 70471 GSK Investigational Site Metairie, Louisiana, United States, 70006 United States, Nebraska GSK Investigational Site Lincoln, Nebraska, United States, 68510 United States, Nevada GSK Investigational Site Las Vegas, Nevada, United States, 89128 United States, New Jersey GSK Investigational Site Lawrenceville, New Jersey, United States, 08648 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27713 GSK Investigational Site Raleigh, North Carolina, United States, 27612 United States, Ohio GSK Investigational Site Englewood, Ohio, United States, 45322 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15206 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 Less <<
NCT02257359 Embryo Transfer Phase 1 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT02213029 Embryo Transfer Phase 1 Terminated - United States, California ... More >> GSK Investigational Site Glendale, California, United States, 91206 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21225 Less <<
NCT00549211 Obstetric Labour, Premature ... More >> Premature Ejaculation Less << Phase 1 Completed - United States, Indiana ... More >> GSK Investigational Site Evansville, Indiana, United States, 47714 Less <<
NCT01021553 Premature Ejaculation Phase 2 Completed - United States, California ... More >> GSK Investigational Site San Diego, California, United States, 92120 GSK Investigational Site San Jose, California, United States, 95128 United States, Indiana GSK Investigational Site Fort Wayne, Indiana, United States, 46825 United States, New York GSK Investigational Site New York, New York, United States, 10016 United States, Pennsylvania GSK Investigational Site Bala-Cynwyd, Pennsylvania, United States, 19004 GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 Netherlands GSK Investigational Site Amsterdam, Netherlands, 1081 HV GSK Investigational Site Utrecht, Netherlands, 3584 CJ Less <<
NCT01669083 Embryo Transfer Phase 1 Completed - United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Less <<
NCT02703181 Embryo Transfer Phase 1 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT01021553 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.93mL

0.39mL

0.19mL

9.64mL

1.93mL

0.96mL

19.28mL

3.86mL

1.93mL

 

Historical Records

Categories